BPC-157 Research Overview
BPC-157 is a pentadecapeptide (15 amino acid sequence) derived from gastric juice protein, extensively investigated in preclinical research for its tissue repair mechanisms. The compound consists of the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val with molecular weight 1419.53 g/mol. This Xeno Labs preparation provides researchers at Stroid UK Shop with laboratory-grade material for investigating BPC-157’s reported effects on angiogenesis pathways, nitric oxide modulation, and GABAergic system interactions in controlled experimental environments.
Laboratory Applications
Research laboratories examine BPC-157 for its reported influence on cellular repair processes in animal models. Studies have investigated the peptide’s effects on tendon, ligament, and bone tissue regeneration mechanisms. The compound has been studied for its potential modulation of vascular endothelial growth factor (VEGF) expression and nitric oxide synthase activity. Researchers working with BPC-157 peptide compounds often examine its interaction with growth factors and inflammatory mediators in tissue culture systems. The peptide’s stability in various pH conditions and its activity across different cell lines make it valuable for comparative peptide research alongside other peptides and SARMs investigations.
Product Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Body Protection Compound 157 |
| CAS Number | 137525-51-0 |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Molecular Weight | 1419.53 g/mol |
| Form | Lyophilised powder |
| Storage | -20°C (powder), 2-8°C (reconstituted) |
Research Compliance
This BPC-157 preparation is intended exclusively for in-vitro research applications and is not approved for human consumption, therapeutic use, or clinical applications. Researchers must handle this compound according to laboratory safety protocols and applicable regulations governing research chemicals.
